Skip to main content
Download PDF

Development of a novel approach for restoration of the meniscus using silk-elastin in a rabbit meniscus injury model

BMC Musculoskeletal Disorders volume 25, Article number: 545 (2024) Cite this article

Abstract

Background

Limited healing potential of the meniscus remains a burden for the successful repair of meniscus injuries in the orthopaedic fields. Silk-elastin (SE) is a novel recombinant protein with favorable properties for wound healing. This proof-of-concept study aimed to investigate the therapeutic effect of silk-elastin in a rabbit meniscal defect model.

Methods

A migration assay using rabbit meniscus and synovial cells with various concentrations of SE in a culture medium was conducted to investigate the mechanism of meniscal healing by SE. Additionally, cylindrical defects with a 1.5 mm diameter were created at the anterior horn of the medial meniscus of rabbits. The animals were divided into three groups: 1) the Blank group; defect only, 2) the Col I group; implantation of type I atelocollagen sponge, and 3) the SE group; implantation of SE (150 mg/ml) sponge. Whole medial menisci were harvested at 4, 8, 12, and 24 weeks after surgery. Histological analyses including immunohistochemical staining were performed to assess meniscal healing.

Results

In vitro study, Migration assay demonstrated a significantly higher number of migrated cells only in synovial cells. Especially, the SE concentration of 10 µg/mL demonstrated the highest number of migrated cells compared with other concentrations. In vivo study, the SE group exhibited significantly higher Ishida scores than other groups at all time points. Furthermore, the SE group showed higher synovial coverage scores than the Col I group at 4 and 8 weeks. Immunohistochemical staining demonstrated higher type II collagen staining in the SE group compared to other groups at 12 weeks. Implanted SE was efficiently replaced by safranin-O staining positive tissue within 8 weeks.

Conclusions

SE could effectively repair a meniscal defect by inducing coverage of synovial cells. SE has the potential to be a useful material for meniscal repair.

Peer Review reports

Introduction

Meniscal injuries, most frequently tears, are a common and important source of knee dysfunction and disability, with an annual incidence of 66 per 100,000 people [1]. Partial meniscectomy is recognized as a well-tolerated treatment option [2]. However, meniscectomy has been reported to accelerate the degeneration of articular cartilage due to alteration of stress distribution, which leads to osteoarthritis of the knee joint [3]. Despite these clinical concerns, meniscectomy is indicated as the first-line treatment for many meniscal tears and is performed at a rate 5 to 24 times higher than meniscal repair [4,5,6]. The poor reparative capacity of the meniscus, especially in the avascular inner zone of the meniscus, and the difficulty of meniscus suture techniques are among the reasons for this situation. Therefore, various attempts have been made to preserve the meniscus.

Like any other tissue regeneration strategy, meniscus tissue engineering also has three major essentials such as cell source, biomolecules, and biomaterials [7]. Since recent developments in science and technology have led to significant advances in materials, we focused on the application of biomaterials for meniscus regeneration. Scaffolds for meniscus tissue engineering are made up of natural, synthetic, or composite polymers [8]. The physicochemical requirements of ideal scaffolds are easy processability to desired shapes, adequate mechanical strength, porous (large surface-to-volume ratio), biodegradable, and biocompatible so that it can provide an adequate environment for cellular proliferation and extracellular matrix synthesis [9].

Out of the variety of scaffolds for meniscal repair used in vivo, only two of these, CMI® and Actifit® were introduced into clinical practice. The first one is a collagen-based implant released in the late 90ies, whereas the latter one is a polyurethane-based scaffold which reached the market a few years later. Both are cell-free scaffolds which aim at promoting regeneration of meniscal fibrocartilage by stimulating resident stromal cells from adjacent tissues, especially synovium. Safety and efficacy data of these scaffolds for meniscal healing and inherent cartilage protection were reported [10,11,12,13,14,15,16,17,18,19,20,21]. However, it takes time for the tissue to be replaced and may fail due to mechanical stress before it is replaced, a complete meniscal healing has been seen only occasionally and we are still far from reaching it with the current technologies. Accordingly, new scaffolds should be manufactured with appropriate biomechanical properties that match those required for normal joint function while new tissue is being formed. Furthermore, they should be easily replaced by regenerated tissue [22].

Silk-elastin (SE) is a protein generated by recombinant DNA technology with relevant genes of silkworm fibroin and human elastin to generate peptide repeats of the silk-fibroin derived sequence (GAGAGS) and elastin-derived sequence (GVGVP) [23]. Previously, it was reported that SE hydrogels have the potential to accelerate wound healing in decubitus ulcers in diabetic mice and SE activates the cell migration ability of mouse fibroblasts and macrophages [24, 25]. SE has not only a high cell affinity and rich elasticity but also another unique feature of its variety of form, from gel to sponge. With modification of manipulation, the sponge form with various stiffness to tolerate mechanical force could be obtained. Previously, it was reported that SE sponges can manage and promote regeneration of bronchial epithelium in Beagle dogs and is safe for chronic skin ulcers in human [26, 27]. These biological and mechanical properties of SE will have favorable effects and could be a novel solution for meniscus repair. In this study, SE was focused as a scaffold on acceleration meniscal repair using its sponge form. The purpose of this study is to investigate the therapeutic effect of SE in rabbit meniscal defect models. We hypothesized that 1) SE would induce migration of cells (meniscal cells and synovial cells), and 2) SE would induce good tissue remodeling when implanted into the injured meniscus.

Materials and methods

Study design

The study was carried out strictly in accordance with the ARRIVE guidelines and the Guidelines for Animal Experimentation at our institution. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of the Graduate School of Biomedical Sciences, Hiroshima University (approval number: A17-103). To investigate mechanism of action of SE, transwell migration assay was carried out. The meniscal and synovial cells from Japanese white rabbit (2.5 to 3.0 kg, Kitayama Labes Co., Ltd., Nagano, Japan) were seeded onto transwell inserts in 12-well plates with culture medium containing various concentration of SE. After 12 h, migrated cells were stained with 4′,6-diamidino-2-phenylindole and counted under fluoromicroscope. In vivo study consisted of 2 treatment groups and a control group. A cylindrical punch defect was created in the avascular zone at the anterior horn of medial meniscus in Japanese white rabbit (2.5–3.0 kg). To eliminate the influence of gender differences, the rabbits were gendered as male. Two treatment approaches comprised two different materials, i.e. type I collagen or SE sponges (n = 6 in each group). In a control group (n = 6), only cylindrical defects in medial meniscus were created. Rabbits were sacrificed 4, 8, 12, and 24 weeks after surgeries.

Transwell migration assay

The migration ability of rabbit meniscal cell and rabbit synovial cells in SE was investigated using a migration assay. Synovial and meniscus tissues were collected from the rabbit’s bilateral knee joints (n = 2), and rinsed 3 times in Phosphate buffered saline to remove blood and fat, cut into pieces not exceeding 1 mm3. Synovial tissues were placed dots in the bottom of the culture dishes and were cultured in Dulbecco’s Modified Eagle’s Medium (FUJIFILM Wako Pure Chemical Co., Osaka, Japan) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific Co., Ltd., Tokyo, Japan). When the outgrowth cells reached 80–90% confluence, synovial tissues were removed and 0.25% trypsin was used to passage cells, and 3–5 generations were used for in vitro study. Meniscus cells were isolated using 1% collagenase I (Worthington Biochemical Co., Lakewood, NJ) for 4 h at 37 °C in an incubator with 5% CO2. After centrifugation at 1,500 rpm for 5 min, cell pellets were suspended in a medium and plated in the culture dish. Mediums in which different amounts of SE were dissolved (SEM) were prepared for the purpose of investigating whether the migration ability changed depending on the concentration. The cultivation prepared with serum-free medium and 10% fetal bovine serum supplemented medium were used for positive control. The manufactured kit (CytoSelect Boyden Chamber Cell Migration/Invasion Assay, Funakoshi Co., Ltd., Tokyo, Japan) was used in the experiment. The cell suspension is added to the upper chamber and incubated for 12 h. Through the polycarbonate membrane, migrating cells adhere to the bottom surface of the membrane and non-migrating cells remain in the upper chamber. After removing the non-migrating cells, the migrating cells were stained with 4′,6-diamidino-2-phenylindole. Migrated cells were imaged with a fluorescence microscope (BZ-9000, Keyence, Osaka, Japan) and quantified. Synovial and meniscus cells were collected from another two rabbit’s bilateral knee joints (n = 4) and migration assay were carried out using for each cell in duplicate. The average value for a total of four experiments was calculated.

Surgical procedure

A total of 38 Japanese white rabbits weighing 2.5 to 3.0 kg were used in this study (Kitayama Labes Co., Ltd., Nagano, Japan). Surgical procedures were performed according to previously reports [28, 29]. Under general anesthesia using ketamine hydrochloride and xylazine, surgery was performed. Through a medial parapatellar approach, the patella was dislocated laterally and the medial meniscus was disclosed. Full thickness cylindrical defects with a 1.5 mm diameter were made in the avascular zone of the anterior horn of the medial meniscus by using a biopsy punch (Kai Medical, Gifu, Japan) (Fig. 1). The 72 defects from 36 rabbits were divided into 3 groups according to treatment as follows: 1) the Blank group (blank defect), 2) the Col I group (defect implantation with type I atelocollagen sponge (Mighty, Koken, Japan)), and 3) the SE group (defect implantation with SE sponge (150 mg/ml)). Since type II collagen is not commercially available in sponge or solid form, type I collagen, which is used clinically, was used as a control group. For SE implantation, SE was prepared as previously described [27, 30] and was provided by Sanyo Chemical, Kyoto, Japan. The concentration of silk-elastin in the sponges was 150 mg/mL considering hydrophilicity and cell migration ability. The device was 1.5 mm in diameter and 3 mm in thickness. The joint capsule and skin were sutured as separate layers in all groups. After surgery, all rabbits were returned to their cages and allowed to move freely without joint immobilization. Whole medial menisci were harvested at 4, 8, 12, and 24 weeks after surgery (N = 6 in each group). The two knees from a rabbit were created by the same surgical procedure as a Time 0 model of SE implantation, and the other two knees from another rabbit were used as a normal model.

Fig. 1
figure 1

Transplantation of the silk elastin (SE) sponge into the meniscal defect. A Creating full thickness cylindrical defect with 1.5 mm diameter. B Meniscal defect at the anterior horn of the medial meniscus. C Transplantation of the SE sponge. D After transplantation. Bars; 5 mm

Full size image

Histological analysis

After the whole medial meniscus was resected from the knee, radial sections were made at the anterior portion. The samples were embedded in paraffin and sectioned at a thickness of 4.5 µm, deparaffinized in xylene, dehydrated using an ethanol series, and stained with safranin-O / fast green and hematoxylin & eosin (HE). Histological sections stained with safranin-O / fast green were blinded and evaluated using Ishida scoring system which includes 3 assessment points: 1) reparative tissue with bonding, assessing whether the reparative tissues had bonded with the surrounded normal meniscus tissues, 2) the existence of fibrochondrocytes, and 3) stainability with safranin-O [4]. In order to enforce a more accurate assessment of the above three items, we modified the Ishida score so that 0% is 0, ~ 25% is 0.5, 25–50% is 1, 50–75% is 1.5, and 75–100% is 2. The total score was kept at 6, as a higher score means a better restoration was obtained. In addition, synovial cell migration toward the implanted sites in the Col I and the SE groups of HE-stained sections was evaluated using the synovial coverage scoring system based on that developed by Nakagawa et al. [31] (Table 1).

Table 1 Synovial coverage scoring for meniscus healing. The score is determined by the number of layers of synovial cells present in the lesion. The score is determined by the number of synovial cell layers on the surface of the implanted area
Full size table

Immunohistochemical analysis

Immunohistochemical staining was carried out on a series of 5 um thick sections. The sections were pretreated with antigen retrieval reagent (Immunoactive; Matsunami Glass Ind) for 1 h followed by 0.3% H2O2 for 30 min, normal blocking serum for 30 min, and primary antibody against type I collagen (1:250 dilution; Novus Biologicals) and type II collagen (1:100 dilution; Daiichi Fine Chemical) overnight at 4 °C. On the next day, the sections were visualized using the avidin–biotin system (Vectastain Elite ABC Mouse IgG kit; Vector Laboratories Inc) and 3,3#-diaminobenzidine (Peroxidase Substrate Kit; Vector Laboratories Inc), according to the manufacturer’s instructions. The staining ratio of type I and II collagen was calculated as the collagen staining scores. Using Zellner's scoring system [32] as a reference, we assigned a staining rate of 0% to 0, ~ 25% to 1, 25–50% to 2, 50–75% to 3, and 75–100% to 4. For detection of SE localization, rabbit polyclonal antibody against SE (dilution, 1: 1000) was used and prepared sections were stained following the same protocol as described above.

Statistical analysis

The results were expressed as means ± standard deviation. The Ishida scores and the collagen staining scores were analyzed with the Student–Newman–Keuls method. The number of migrated cells and the synovial coverage scores were analyzed with the Mann–Whitney test (Prism, GraphPad Software, MA, USA). P values < 0.05 were statistically significant.

Results

Cell migration to SE medium

Almost no migration of meniscal cells was confirmed with various concentrations of SEM. On the other hand, in synovial cells, the number of migrating cells changed depending on the concentration of SEM, and the number of cells was the largest at 10 μg/ml of SE, and the number of cells decreased when the concentration was further increased. The migration ability of synovial cells to SE was confirmed (Fig. 2).

Fig. 2
figure 2

Migration assay using synovial and meniscal cells in the different concentration of SE containing medium (SEM). A Synovium cells. B Meniscal cells. Bars; 100 μm (C) Standardized number of migrated cells

Full size image

Histological analysis stained with safranin-O / fast green

The Blank group showed scar-like tissue formation at 4 weeks, although the spread of fibrochondrocytes and staining with safranin-O were poor. At 8 weeks, staining with safranin-O was observed, however, the spread of cells was sparse. At 12 weeks, fibrochondrocytes were partially present and stained densely with safranin-O. The formation of cartilage-like tissue was observed, although there was insufficient bonding to the surrounding tissue and scar-like tissue was still observed. At 24 weeks, the extent of cartilage-like tissue increased and the bonding to the surrounding tissue improved. In the Col I group, the implanted scaffold was still present at 4 weeks, and bonding to the surrounding meniscus was observed, although cell spreading and safranin-O staining were poor. At 8 weeks, the scaffold was absorbed and adhesion was poor, and at 12 weeks, some fibrochondrocytes were confirmed and chondrocyte-like tissue stained with safranin-O at 12 weeks, some fibrocartilage cells were present and cartilage-like tissue stained with safranin-O was formed. However, the bonding to the surrounding tissue was poor. At 24 weeks, the extent of cartilage-like tissue became broader with the replacement of the scaffold and the bonding to the surrounding tissue improved. In the SE group, both fibrochondrocytes and safranin-O staining were already present at 4 weeks. At 8 and 12 weeks, fibrochondrocytes were more widespread and safranin-O staining was more intense. At 24 weeks, fibrochondrocytes were present throughout and safranin-O staining remained intense, however, its staining was reduced compared to that at 12 weeks and still higher level compared to the normal meniscal tissue. The Ishida score was significantly higher in the SE group than in the Blank and Col I groups at 4, 8, and 12 weeks, and there was no significant difference between the Blank and Col I groups. At 24 weeks, there was no significant difference between the SE group, Blank group, and Col I group (Fig. 3).

Fig. 3
figure 3

A-D Safranin-O staining of the medial meniscus in the normal, Blank, Col I and SE groups. Bars: 500 μm. E Modified Ishida score. SO/FG: Safranin O / Fast green

Full size image

Histological analysis stained with HE

In the Col I group, 75% of the sections were not covered by synovium, and even the sections that were covered did not have more than 6 layers. In the SE group, all sections had 1–5 layers of synovial cells and 67% of the sections had 3 or more layers at 4 weeks. At 8 weeks, 3 or more layers of synovial cells were present, and 50% of the sections had 6 or more layers. At 12 weeks, the synovial layer had decreased, with no sections having more than 6 layers, and 33% of sections having 0 layers. At 24 weeks, all but one section were not covered with synovial cells, and even the only section was covered with only one layer. The synovial coverage score was significantly higher in the SE group than in the Col I group at 4, and 8 weeks. At 12 and 24 weeks, there was no significant difference between the SE group and Col I group (Fig. 4).

Fig. 4
figure 4

Histology of synovial coverage. A Hematoxylin & eosin staining of the medial meniscus in the Col I and SE groups. Bars: 100 μm B Synovial coverage score

Full size image

Immunohistochemical analysis

Immunostaining for type I collagen showed the average score was highest in the order of the Col I group, the Blank group, and the SE group at all time points. In particular, the difference was greatest at 12 weeks, with 50% of the sections in the Col I group showing staining of over 75%, and the staining score was significantly higher than that in the SE group. At 24 weeks, the staining ratio decreased in all groups, and even in the Col-I group, there were no sections with more than 50% staining, and there was no significant difference among the three groups (Fig. 5).

Fig. 5
figure 5

Immunohistochemistry of Col I. A Immunostaining for type I collagen in the Blank, Col I and SE groups. *; defect site. Bars; 100 μm (B) The type I collagen staining score

Full size image

For type II collagen immunostaining, the SE group had the highest mean score at all time points. Similar to col-I staining, the difference was greatest at 12 weeks. Staining of 75% or higher was observed in 67% of the sections in the SE group, while no staining of 50% or higher was observed in the other two groups, with the SE group having a significantly higher staining score than the Blank and Col I groups. At 24 weeks, the staining rate increased in both the Col-I group and the Blank group, and there was no significant difference among the three groups (Fig. 6).Immunostaining of SE showed localization of SE was observed immediately after transplantation at the defect site. Although SE localization was still presented at 4 weeks, the grafted area had been replaced with safranin-O stained areas. At 8 weeks, it was difficult to confirm SE stained area (Fig. 7).

Fig. 6
figure 6

Immunohistochemistry of Col II. A Immunostaining for type II collagen in the Blank, Col I and SE groups. *; defect site. Bars; 100 μm (B) The type II collagen staining score

Full size image
Fig. 7
figure 7

Immunohistochemistry of SE in the SE group. *; defect site. Bars; 100 μm

Full size image

Discussion

The present study revealed that SE sponge was biocompatible and could induce good meniscal repair through the promotion of the migration of synovial cells to the injured area in the meniscus in rabbit models. SE promoted superior meniscus repair with fibrocartilage cells, glycosaminoglycan-rich tissue, and type II collagen compared to the control groups (Blank and Col I), which suggests that SE has the potential to be an ideal material for meniscal repair.

Regarding the selection of cell sources for meniscus repair, meniscal cells [33], chondrocytes [34], and mesenchymal stem cells (MSCs) derived from bone marrow [35], fat tissue [36] or synovium [37] have been used. Kim et al. performed freeze–thaw treatment on the meniscus and synovium of Japanese white rabbits to investigate the therapeutic effect of a cylindrical defect of 2 mm-diameter filled with alginate gel. They found that the defects were filled with fibrochondrocytes and proteoglycan when the synovium was intact and concluded that synovial cells were the primary contributors to meniscal injury repair [38]. Nakagawa et al. transplanted synovial MSCs to longitudinal tears in the avascular region of the meniscus in pigs and concluded that synovial MSC transplantation promotes meniscal healing by guiding the synovium to the injured region [31]. In our vitro experiments, synovial cells migrated toward the medium containing SE solution, while meniscal cells did not. In our vivo experiments, almost no synovial cell induction was observed in the Col-I group, while vigorous synovial cell induction was observed in the SE group at 4 and 8 weeks. These results suggest that SE application at the lesion could have the potential to early recruit synovial cells that are a major contributor to meniscal repair. Although the detailed mechanism by which SE promotes synovial cell migration remains to be determined, this feature would be a mode of action of SE for acceleration of meniscal healing.

A semi-quantitative scoring system was developed by Ishida in 2007 to evaluate the regeneration of meniscal tissue in vitro and in vivo after platelet-rich plasma application [29]. Longo et al. [39] validated the histological scoring system and reported that the Ishida score is the most adequate for the evaluation of tissue-engineered meniscal repair, and it has been used in many reports [40,41,42,43,44] of meniscus repair using scaffolds. However, since the scoring is based on three levels (0, 1, and 2), the interpretation of partial repair is ambiguous, and the possible existence of various tissues within the score of 1 was considered to be a problem. Therefore, we modified the tissue scoring to five levels (0, 0.5, 1, 1.5, 2), which could better reflect the tissue repair. Of the three items in the Ishida score, the existence of fibrochondrocytes and staining with safranin-O were particularly early in the SE group, and the tissue matured with time, suggesting that SE contributes to accelerated repair of meniscus injuries in the early stage. Nevertheless, it does not include a specific assessment of the “collagen organization”. Thus, we considered it should be used in association with another score, evaluating the distribution of collagen fibers in the meniscal tissue. Microscopically, the meniscus can be distinguished into a peripheral red zone and a medial, vessel-free white zone [45]. The peripheral zone presents abundant type I collagen deposition and many elongated fibroblast-like cells. In contrast to the peripheral zone, the medial zone is characterized by chondrocyte-like cells embedded in type II collagen and glycosaminoglycans [46, 47]. Zellner et al. developed a scoring system in 2010 for the macroscopic, histological, and immunohistochemical evaluation of avascular meniscal punch defect repair. This scoring system has been used in several reports about meniscal repair [48, 49]. The content of type II collagen is one of the immunohistological items, and is classified into four levels, with the higher the content, the better the repair. We modified the content ratio into five levels (0, 1, 2, 3, 4) and scored each of Type I and II collagen. The Col-I staining rate was generally high in the Col-I group, and the SE group showed high scores for Col-II staining from early after transplantation, suggesting that type II collagen production was promoted along with good tissue repair.

As commercially available materials for meniscal repair, CMI® scaffolds showed poor biomechanical properties, which could lead to iatrogenic damage of the scaffold during implant positioning and suture [50]. To overcome these problems, Actifit® has been developed claiming superior mechanical properties. While intra-operatively this was perceived as a sufficient strength by surgeons, this may be not enough to sustain the high joint stresses, with even weight bearing and simple walking causing numerous and critical stress cycles [8]. Only one prospective, non-randomized trial compared the outcomes of CMI® and Actifit® scaffolds [21]. CMI® was mainly replaced by fibrous tissue, whereas an avascular cartilaginous-like tissue was present in the case of the Actifit®. In all cases, the scaffolds were still visible at the macroscopic and microscopic levels, suggesting an incomplete meniscal healing process after two years from implantation. Thus, more biocompatible material with appropriate mechanical and biological properties has been desired in clinical practice for the successful treatment of meniscal defects. In our study, the implanted SE sponge was efficiently replaced by safranin-O staining positive tissue within 8 weeks, suggesting that residual materials in the meniscus does not interfere with the meniscus healing. In addition, SE sponge has already been clinically applied for chronic skin ulcers and its safety for human has been confirmed [27]. SE has the potential to be an ideal scaffold for meniscal repair in terms of its cell migration ability, ability to provide a three-dimensional framework for tissue repair, and ease of handling. However, although high concentrations of silk elastin improved the ease of handling, it was shown to physically inhibit cell migration, so it is necessary to investigate optimal condition in the future.

There were several limitations to the current study. First, the evaluations of the mechanical strength of repaired tissue and knee joint cartilage wear were not performed in this study. This data will be required for future clinical applications. Second, the SE used in this study does not have enough mechanical properties for suture application due to its hydrophilic nature. Improvement of this mechanical property will be important for applying large meniscal defects to stabilize implanted material with sutures and tolerate mechanical stress during activity until tissue formation. Thirdly, the experiment was conducted in an atypical injury model in clinical practice using rabbits and followed a limited experimental period, a maximum of 6 months. In terms of injury site, we created defect at white-white zone. The effect on the red-red or red-white zones injury models may also need to be investigated. However, as the effect of SE on meniscus repair has been confirmed in white-white zone with poor healing capacity, it may not be possible to fully compare the effect of SE on meniscus repair in red-red or red-white zones where healing is fully expected to be adequate. To confirm the efficacy of SE for meniscal healing and to consider clinical application, large animal experiments, such as the pig model, experiments in injury models that are likely to occur clinically, and longer follow-ups will be required in the near future.

Conclusion

SE has the property to induce synovial cell migration, but it does not affect meniscal cells. Implantation of SE sponge into meniscal defects accelerates meniscal healing with fibrochondrocytes and glycosaminoglycan- and type II collagen-rich tissues by inducing synovial coverage in rabbits. SE has the potential to be a useful material for meniscal repair.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

HE:

Hematoxylin & eosin

MSC:

Mesenchymal stem cell

SE:

Silk-elastin

SEM:

Silk-elastin containing medium

References

  1. Hede A, Jensen DB, Blyme P, Sonne-Holm S. pidemiology of meniscal lesions in the knee. 1,215 open operations in Copenhagen 1982–84. Acta Orthop Scand. 1990;61(5):435–7. https://doi.org/10.3109/17453679008993557.

    Article  CAS  PubMed  Google Scholar 

  2. Chatain F, Adeleine P, Chambat P, Neyret P. A comparative study of medial versus lateral arthroscopic partial meniscectomy on stable knees: 10-year minimum follow-up. Arthroscopy. 2003;19(8):842–9. https://doi.org/10.1016/S0749-8063(03)00735-7.

    Article  CAS  PubMed  Google Scholar 

  3. Papalia R, Del Buono A, Osti L, Denaro V, Maffulli N. Meniscectomy as a risk factor for knee osteoarthritis: a systematic review. Br Med Bull. 2011;99:89–106. https://doi.org/10.1093/bmb/ldq043.

    Article  PubMed  Google Scholar 

  4. Chung KS, Ha JK, Kim YS, Kim JH, Ra HJ, Kong DH, et al. National trends of meniscectomy and meniscus repair in Korea. J Korean Med Sci. 2019;34(32):e206. https://doi.org/10.3346/jkms.2019.34.e206.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Montgomery SR, Zhang A, Ngo SS, Wang JC, Hame SL. Cross-sectional analysis of trends in meniscectomy and meniscus repair. Orthopedics. 2013;36:e1007–13. https://doi.org/10.3928/01477447-20130724-15.

    Article  PubMed  Google Scholar 

  6. Abrams GD, Frank RM, Gupta AK, Harris JD, McCormick FM, Cole BJ. Trends in meniscus repair and meniscectomy in the United States, 2005–2011. Am J Sports Med. 2013;41(10):2333–9. https://doi.org/10.1177/0363546513495641.

    Article  PubMed  Google Scholar 

  7. Pillai MM, Gopinathan J, Selvakumar R, Bhattacharyya A. Human knee meniscus regeneration strategies: a review on recent advances. Curr Osteoporos Rep. 2018;16(3):224–35. https://doi.org/10.1007/s11914-018-0436-x.

    Article  PubMed  Google Scholar 

  8. Li H, Li P, Yang Z, Gao C, Fu L, Liao Z, et al. Meniscal regenerative scaffolds based on biopolymers and polymers: recent status and applications. Front Cell Dev Biol. 2021;9: 661802. https://doi.org/10.3389/fcell.2021.661802.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kanani AG, Bahrami SH. Review on electrospun nanofibers scaffold and biomedical applications. Trends Biomater Artif Organs. 2010;24(2):93–115.

    Google Scholar 

  10. Zaffagnini S, Marcheggiani Muccioli GM, Lopomo N, Bruni D, Giordano G, Ravazzolo G, et al. Prospective long-term outcomes of the medial collagen meniscus implant versus partial medial meniscectomy: a minimum 10-year follow-up study. Am J Sports Med. 2011;39(5):977–85. https://doi.org/10.1177/0363546510391179.

    Article  PubMed  Google Scholar 

  11. Zaffagnini S, Marcheggiani Muccioli GM, Bulgheroni P, Bulgheroni E, Grassi A, Bonanzinga T, et al. Arthroscopic collagen meniscus implantation for partial lateral meniscal defects: a 2-year minimum follow-up study. Am J Sports Med. 2012;40(10):2281–8. https://doi.org/10.1177/0363546512456835.

    Article  PubMed  Google Scholar 

  12. Kovacs BK, Huegli R, Harder D, Cedro L, Berbig R, Amsler F, et al. MR variability of collagen meniscal implant remodelling in patients with good clinical outcome. Knee Surg Sports Traumatol Arthrosc. 2021;29(1):90–9. https://doi.org/10.1007/s00167-019-05715-9.

    Article  PubMed  Google Scholar 

  13. De Coninck T, Huysse W, Willemot L, Verdonk R, Verstraete K, Verdonk P. Two-year follow-up study on clinical and radiological outcomes of polyurethane meniscal scaffolds. Am J Sports Med. 2013;41(1):64–72. https://doi.org/10.1177/0363546512463344.

    Article  PubMed  Google Scholar 

  14. Filardo G, Kon E, Perdisa F, Sessa A, Di Martino A, Busacca M, et al. Polyurethane-based cell-free scaffold for the treatment of painful partial meniscus loss. Knee Surg Sports Traumatol Arthrosc. 2017;25(2):459–67. https://doi.org/10.1007/s00167-016-4219-6.

    Article  CAS  PubMed  Google Scholar 

  15. Kon E, Filardo G, Zaffagnini S, Di Martino A, Di Matteo B, Marcheggiani Muccioli GM, et al. Biodegradable polyurethane meniscal scaffold for isolated partial lesions or as combined procedure for knees with multiple comorbidities: clinical results at 2 years. Knee Surg Sports Traumatol Arthrosc. 2014;22(1):128–34. https://doi.org/10.1007/s00167-012-2328-4.

    Article  PubMed  Google Scholar 

  16. Monllau JC, Poggioli F, Erquicia J, Ramirez E, Pelfort X, Gelber P, et al. Magnetic resonance imaging and functional outcomes after a polyurethane meniscal scaffold implantation: minimum 5-year follow-up. Arthroscopy. 2018;34(5):1621–7. https://doi.org/10.1016/j.arthro.2017.12.019.

    Article  PubMed  Google Scholar 

  17. Baynat C, Andro C, Vincent JP, Schiele P, Buisson P, Dubrana F, et al. Actifit synthetic meniscal substitute: experience with 18 patients in Brest. France Orthop Traumatol Surg Res. 2014;100(8 Suppl):S385–9. https://doi.org/10.1016/j.otsr.2014.09.007.

    Article  CAS  PubMed  Google Scholar 

  18. Toanen C, Dhollander A, Bulgheroni P, Filardo G, Zaffagnini S, Spalding T, et al. Polyurethane meniscal scaffold for the treatment of partial meniscal deficiency: 5-year follow-up outcomes: a European multicentric study. Am J Sports Med. 2020;48(6):1347–55. https://doi.org/10.1177/0363546520913528.

    Article  PubMed  Google Scholar 

  19. Akkaya M, Simsek ME, Gursoy S, Cay N, Bozkurt M. Medial meniscus scaffold implantation in combination with concentrated bone marrow aspirate injection: minimum 3-year follow-up. J Knee Surg. 2020;33(8):838–46. https://doi.org/10.1055/s-0040-1701452.

    Article  PubMed  Google Scholar 

  20. Condello V, Dei Giudici L, Perdisa F, Screpis DU, Guerriero M, Filardo G, et al. Polyurethane scaffold implants for partial meniscus lesions: delayed intervention leads to an inferior outcome. Knee Surg Sports Traumatol Arthrosc. 2021;29(1):109–16. https://doi.org/10.1007/s00167-019-05760-4.

    Article  PubMed  Google Scholar 

  21. Bulgheroni E, Grassi A, Campagnolo M, Bulgheroni P, Mudhigere A, Gobbi A. Comparative study of collagen versus synthetic-based meniscal scaffolds in treating meniscal deficiency in young active population. Cartilage. 2016;7(1):29–38. https://doi.org/10.1177/1947603515600219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Veronesi F, Di Matteo B, Vitale ND, Filardo G, Visani A, Kon E, et al. Biosynthetic scaffolds for partial meniscal loss: a systematic review from animal models to clinical practice. Bioact Mater. 2021;6(11):3782–800. https://doi.org/10.1016/j.bioactmat.2021.03.033.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Gustafson J, Greish K, Frandsen J, Cappello J, Ghandehari H. Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. J Control Release. 2009;140(3):256–61. https://doi.org/10.1016/j.jconrel.2009.05.022.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kawabata S, Kanda N, Hirasawa Y, Noda K, Matsuura Y, Suzuki S, et al. The utility of silk-elastin hydrogel as a new material for wound healing. Plast Reconstr Surg Glob Open. 2018;6(5):e1778. https://doi.org/10.1097/GOX.0000000000001778.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ozaki C, Somamoto S, Kawabata S, Tabata Y. Effect of an artificial silk elastin-like protein on the migration and collagen production of mouse fibroblasts. J Biomater Sci Polym Ed. 2014;25(12):1266–77. https://doi.org/10.1080/09205063.2014.926580.

    Article  CAS  PubMed  Google Scholar 

  26. Ueda Y, Somamoto S, Kawabata S, Midorikawa K, Miyahara S, Waseda R, et al. Development of a novel material to promote wound healing at bronchial defects. Ann Thorac Surg. 2023;116(2):239–45. https://doi.org/10.1016/j.athoracsur.2022.06.026.

    Article  PubMed  Google Scholar 

  27. Noda K, Kawai K, Matsuura Y, Ito-Ihara T, Amino Y, Ushimaru M, et al. Safety of silk-elastin sponges in patients with chronic skin ulcers: a phase I/II, single-center, open-label, single-arm clinical trial. Plast Reconstr Surg Glob Open. 2021;9(4):e3556. https://doi.org/10.1097/GOX.0000000000003556.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kobayashi K, Fujimoto E, Deie M, Sumen Y, Ikuta Y, Ochi M. Regional differences in the healing potential of the meniscus-an organ culture model to eliminate the influence of microvasculature and the synovium. Knee. 2004;11(4):271–8. https://doi.org/10.1016/j.knee.2002.03.001.

    Article  PubMed  Google Scholar 

  29. Ishida K, Kuroda R, Miwa M, Tabata Y, Hokugo A, Kawamoto T, et al. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng. 2007;13(5):1103–12. https://doi.org/10.1089/ten.2006.0193.

    Article  CAS  PubMed  Google Scholar 

  30. Kawabata S, Kawai K, Somamoto S, Noda K, Matsuura Y, Nakamura Y, et al. The development of a novel wound healing material, silk-elastin sponge. J Biomater Sci Polym Ed. 2017;28:2143–53. https://doi.org/10.1080/09205063.2017.1382829.

    Article  CAS  PubMed  Google Scholar 

  31. Nakagawa Y, Muneta T, Kondo S, Mizuno M, Takakuda K, Ichinose S, et al. Synovial mesenchymal stem cells promote healing after meniscal repair in microminipigs. Osteoarthr Cartil. 2015;23(6):1007–17. https://doi.org/10.1016/j.joca.2015.02.008.

    Article  CAS  Google Scholar 

  32. Zellner J, Mueller M, Berner A, Dienstknecht T, Kujat R, Nerlich M, et al. Role of mesenchymal stem cells in tissue engineering of meniscus. J Biomed Mater Res A. 2010;94(4):1150–61. https://doi.org/10.1002/jbm.a.32796.

    Article  CAS  PubMed  Google Scholar 

  33. Kang SW, Son SM, Lee JS, Lee ES, Lee KY, Park SG, et al. Regeneration of whole meniscus using meniscal cells and polymer scaffolds in a rabbit total meniscectomy model. J Biomed Mater Res A. 2006;78(3):659–71. https://doi.org/10.1002/jbm.a.30579.

    Article  CAS  PubMed  Google Scholar 

  34. Kon E, Chiari C, Marcacci M, Delcogliano M, Salter DM, Martin I, et al. Tissue engineering for total meniscal substitution: animal study in sheep model. Tissue Eng Part A. 2008;14(6):1067–80. https://doi.org/10.1089/ten.tea.2007.0193.

    Article  CAS  PubMed  Google Scholar 

  35. Yamasaki T, Deie M, Shinomiya R, Yasunaga Y, Yanada S, Ochi M. Transplantation of meniscus regenerated by tissue engineering with a scaffold derived from a rat meniscus and mesenchymal stromal cells derived from rat bone marrow. Artif Organs. 2008;32(7):519–24. https://doi.org/10.1111/j.1525-1594.2008.00580.x.

    Article  CAS  PubMed  Google Scholar 

  36. Moutos FT, Guilak F. Functional properties of cell-seeded three-dimensionally woven poly(epsilon-caprolactone) scaffolds for cartilage tissue engineering. Tissue Eng Part A. 2010;16(4):1291–301. https://doi.org/10.1089/ten.TEA.2009.0480.

    Article  CAS  PubMed  Google Scholar 

  37. Moriguchi Y, Tateishi K, Ando W, Shimomura K, Yonetani Y, Tanaka Y, et al. Repair of meniscal lesions using a scaffold-free tissue-engineered construct derived from allogenic synovial MSCs in a miniature swine model. Biomaterials. 2013;34(9):2185–93. https://doi.org/10.1016/j.biomaterials.2012.11.039.

    Article  CAS  PubMed  Google Scholar 

  38. Kim W, Onodera T, Kondo E, Terkawi MA, Homan K, Hishimura R, et al. Which contributes to meniscal repair, the synovium or the meniscus? An in vivo rabbit model study with the freeze-thaw method. Am J Sports Med. 2020;48(6):1406–15. https://doi.org/10.1177/0363546520906140.

    Article  PubMed  Google Scholar 

  39. Longo UG, Loppini M, Romeo G, Maffulli N, Denaro V. Histological scoring systems for tissue-engineered, ex vivo and degenerative meniscus. Knee Surg Sports Traumatol Arthrosc. 2013;21(7):1569–76. https://doi.org/10.1007/s00167-012-2142-z.

    Article  PubMed  Google Scholar 

  40. Yuan Z, Liu S, Hao C, Guo W, Gao S, Wang M, et al. AMECM/DCB scaffold prompts successful total meniscus reconstruction in a rabbit total meniscectomy model. Biomaterials. 2016;111:13–26. https://doi.org/10.1016/j.biomaterials.2016.09.017.

    Article  CAS  PubMed  Google Scholar 

  41. Li C, Hu X, Meng Q, Zhang X, Zhu J, Dai L, et al. The potential of using semitendinosus tendon as autograft in rabbit meniscus reconstruction. Sci Rep. 2017;7(1):7033. https://doi.org/10.1038/s41598-017-07166-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Gao S, Chen M, Wang P, Li Y, Yuan Z, Guo W, et al. An electrospun fiber reinforced scaffold promotes total meniscus regeneration in rabbit meniscectomy model. Acta Biomater. 2018;73:127–40. https://doi.org/10.1016/j.actbio.2018.04.012.

    Article  CAS  PubMed  Google Scholar 

  43. Otsuki S, Nakagawa K, Murakami T, Sezaki S, Sato H, Suzuki M, et al. Evaluation of meniscal regeneration in a mini pig model treated with a novel polyglycolic acid meniscal scaffold. Am J Sports Med. 2019;47(8):1804–15. https://doi.org/10.1177/0363546519850578.

    Article  PubMed  Google Scholar 

  44. Chen C, Song J, Qiu J, Zhao J. Repair of a meniscal defect in a rabbit model through use of a thermosensitive, injectable, in situ crosslinked hydrogel with encapsulated bone mesenchymal stromal cells and transforming growth factor β1. Am J Sports Med. 2020;48(4):884–94. https://doi.org/10.1177/0363546519898519.

    Article  PubMed  Google Scholar 

  45. Murphy CA, Cunniffe GM, Garg AK, Collins MN. Regional dependency of bovine meniscus biomechanics on the internal structure and glycosaminoglycan content. J Mech Behav Biomed Mater. 2019;94:186–92. https://doi.org/10.1016/j.jmbbm.2019.02.020.

    Article  CAS  PubMed  Google Scholar 

  46. Makris EA, Hadidi P, Athanasiou KA. The knee meniscus: structure-function, pathophysiology, current repair techniques, and prospects for regeneration. Biomaterials. 2011;32(30):7411–31. https://doi.org/10.1016/j.biomaterials.2011.06.037.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Jacob G, Shimomura K, Krych AJ, Nakamura N. The meniscus tear: a review of stem cell therapies. Cells. 2019;9(1). https://doi.org/10.3390/cells9010092.

  48. Abpeikar Z, Javdani M, Alizadeh A, Khosravian P, Tayebi L, Asadpour S. Development of meniscus cartilage using polycaprolactone and decellularized meniscus surface modified by gelatin, hyaluronic acid biomacromolecules: a rabbit model. Int J Biol Macromol. 2022;31(213):498–515. https://doi.org/10.1016/j.ijbiomac.2022.05.140.

    Article  CAS  Google Scholar 

  49. Koch M, Hammer S, Fuellerer J, Lang S, Pfeifer CG, Pattappa G, et al. Bone marrow aspirate concentrate for the treatment of avascular meniscus tears in a one-step procedure-evaluation of an in vivo model. Int J Mol Sci. 2019;20(5):1120. https://doi.org/10.3390/ijms20051120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Rodkey WG, Steadman JR, Li ST. Collagen scaffolds: a new method to preserve and restore the severely injured meniscus. Sports Med Arthrosc. 1999;7(1):63–73.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Y. Takagi, T. Miyata, E. Ueda, and A. Saito for excellent technical support for tissue sectioning, staining and cell culture. A part of this work was carried out at the Analysis Center of Life Science and Research Facilities for Laboratory Animal Science, Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University.

Funding

This work was supported by the Japan Agency for Medical Research and Development (grant number: 20im0210222). Sponsor was not involved in any roles of study designing, data collection, data analysis and interpretation, writing the report and a decision to submit the paper for publication.

Author information

Author notes

  1. Tadashi Inoue and Toshiya Kano as the first author.

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8553, Japan

    Tadashi Inoue, Toshiya Kano, Tomoyuki Nakasa, Naosuke Kamei & Nobuo Adachi

  2. Department of Artificial Joints and Biomaterials, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    Masakazu Ishikawa

  3. Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan

    Shigeru Miyaki

  4. Sanyo Chemical Industries Ltd, Kyoto, Japan

    Keiichiro Inoue & Shingo Kawabata

Authors
  1. Tadashi Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiya Kano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomoyuki Nakasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masakazu Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keiichiro Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shingo Kawabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shigeru Miyaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Naosuke Kamei
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nobuo Adachi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors participated in the study design, have read the final manuscript, and approved it. TI, TK, KI: execution of experiment, aggregate the results, drafting the manuscript. TN, NA: assistance with data interpretation, revisioning the manuscript. MI: execution of experiment, assistance with data interpretation, revisioning the manuscript, statistical analysis. SK, SM, NK: assistance with data interpretation.

Corresponding author

Correspondence to Tomoyuki Nakasa.

Ethics declarations

Ethics approval and consent to participate

The study was carried out strictly in accordance with the ARRIVE guidelines and the Guidelines for Animal Experimentation at our institution. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of the Graduate School of Biomedical Sciences, Hiroshima University (approval number: A17-103).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inoue, T., Kano, T., Nakasa, T. et al. Development of a novel approach for restoration of the meniscus using silk-elastin in a rabbit meniscus injury model. BMC Musculoskelet Disord 25, 545 (2024). https://doi.org/10.1186/s12891-024-07675-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12891-024-07675-9

Keywords

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us